Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    23964690 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants
Condition: Haemophilus Influenzae Type b (Hib) Infection
Intervention: Biological: Haemophilus influenzae type b (Hib) vaccine
2 Completed Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China
Condition: Haemophilus Influenzae Type b (Hib) Infection
Intervention: Biological: Haemophilus influenzae type b (Hib) vaccine

Indicates status has not been verified in more than two years